Drugs / l-LV
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04747951 Background | Oct 2020 → Oct 2023 | rectal cancer | State Scientific Centre of Coloproctology, Russian Federation | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | l-LV | “Administration of l-LV (400 mg/m2) and oxaliplatin (85 mg/ m2) by intravenous infusion over 2 h” NCT04747951 ↗ |
| Route | Intravenous | “l-LV (400 mg/m2) and oxaliplatin (85 mg/ m2) by intravenous infusion over 2 h” NCT04747951 ↗ |